Australia markets closed

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4545-0.1115 (-19.70%)
At close: 04:00PM EDT
0.4501 -0.00 (-0.97%)
After hours: 07:31PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.35M
Enterprise value 3.07M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)7.23
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.13

Trading information

Stock price history

Beta (5Y monthly) 0.09
52-week change 3-95.60%
S&P500 52-week change 323.76%
52-week high 310.6500
52-week low 30.4390
50-day moving average 30.6577
200-day moving average 31.4440

Share statistics

Avg vol (3-month) 376.1k
Avg vol (10-day) 3120.24k
Shares outstanding 57.38M
Implied shares outstanding 67.38M
Float 85.69M
% held by insiders 127.63%
% held by institutions 15.25%
Shares short (15 May 2024) 482.12k
Short ratio (15 May 2024) 40.84
Short % of float (15 May 2024) 41.62%
Short % of shares outstanding (15 May 2024) 41.19%
Shares short (prior month 15 Apr 2024) 414.51k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 331 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Apr 2023
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-166.84%
Return on equity (ttm)-1,196.26%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -12.35M
Net income avi to common (ttm)-12.4M
Diluted EPS (ttm)-1.8200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)282.87k
Total cash per share (mrq)0.04
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.16
Book value per share (mrq)-0.63

Cash flow statement

Operating cash flow (ttm)-9.08M
Levered free cash flow (ttm)-4.58M